Sigyn Therapeutics, Inc. (SIGY) Liabilities and Shareholders Equity (2016 - 2025)
Sigyn Therapeutics (SIGY) recorded Liabilities and Shareholders Equity of $135,571 in Q3 2025, down 68.3% from $427,438 a year earlier but up 161.9% from the prior quarter.
Powered by 
Analysis
Sigyn Therapeutics, Inc. (SIGY) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends
At the end of FY2024, Sigyn Therapeutics reported Liabilities and Shareholders Equity of $213,719, down 33.6% from FY2023.
- Annual Liabilities and Shareholders Equity has declined for three straight years, with a four-year compound annual growth rate of -25.5% (FY2020 to FY2024).
- Across earlier years, Liabilities and Shareholders Equity came in at $321,806 in FY2023 (-3.3%), $332,879 in FY2022 (-53.1%), $710,259 in FY2021 (+2.3%) and $694,082 in FY2020.
- Quarterly Liabilities and Shareholders Equity has ranged from $51,759 in Q2 2025 to $1.99 million in Q2 2021 over the past five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined for four consecutive quarters, with an average decline of 33.2% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 220.0% in Q2 2021, against a decline of 83.8% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $51,759 (Q2 2025), $244,309 (Q1 2025) and $213,719 (Q4 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 135,571.00 |
| Jun 30, 2025 | 51,759.00 |
| Mar 31, 2025 | 244,309.00 |
| Dec 31, 2024 | 213,719.00 |
| Sep 30, 2024 | 427,438.00 |
| Jun 30, 2024 | 320,165.00 |
| Mar 31, 2024 | 323,295.00 |
| Dec 31, 2023 | 321,806.00 |
| Sep 30, 2023 | 387,223.00 |
| Jun 30, 2023 | 361,817.00 |
| Mar 31, 2023 | 660,447.00 |
| Dec 31, 2022 | 332,879.00 |
| Sep 30, 2022 | 362,273.00 |
| Jun 30, 2022 | 395,908.00 |
| Mar 31, 2022 | 447,414.00 |
| Dec 31, 2021 | 710,259.00 |
| Sep 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | 608,960.00 |
| Dec 31, 2020 | 694,082.00 |
API Access
Sigyn Therapeutics, Inc. Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SIGY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SIGY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SIGY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();